EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

Completed

Phase 4 Results

Summary of Purpose

German stroke units are hesitating to use Aggrenox for secondary ischaemic stroke / transient ischaemic attack (TIA) prevention in a sub-acute treatment setting. They argue that clinical experience with sub-acute Aggrenox treatment is limited and poorly documented when compared with sub-acute acetylsalicylic acid (ASA) treatment. However, long term treatment (started after 3-6 months after stroke/TIA) with...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 January 2014.

1 Jul 2007 6 Jul 2007 1 Feb 2009 Unavailable 1 Jan 2014 29 Jan 2010
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Reinhard Dengler, Department of Neurology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany

    dengler.reinhard@mh-hannover.de